Review
doi: 10.1056/NEJM197301042880107.
Treatment of myasthenia gravis
- PMID: 4347296
- DOI: 10.1056/NEJM197301042880107
Item in Clipboard
Review
Treatment of myasthenia gravis
N Engl J Med.
.
No abstract available
Similar articles
-
[Therapy of myasthenia gravis in pregnancy].Minerva Ginecol. 1980 Jan-Feb;32(1-2):21-6. Minerva Ginecol. 1980. PMID: 6245392 Italian. No abstract available.
-
Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.Clin Neuropharmacol. 1982;5(3):277-92. doi: 10.1097/00002826-198205030-00003. Clin Neuropharmacol. 1982. PMID: 6288236 Review. No abstract available.
-
[Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].Med Klin. 1973 Jun 1;68(22):723-30. Med Klin. 1973. PMID: 4715780 German. No abstract available.
-
[On the treatment of myasthenia].Rev Med Liege. 1968 Sep 15;23(18):552-7. Rev Med Liege. 1968. PMID: 4316587 French. No abstract available.
-
[Current therapy of myasthenia gravis. I. Specific symptomatic therapy].Nervenarzt. 1972 Jul;43(7):341-4. Nervenarzt. 1972. PMID: 4627866 Review. German. No abstract available.
Cited by
-
Congenital and hereditary myasthenia.Eur J Pediatr. 1982 Jul;138(4):349-51. doi: 10.1007/BF00442516. Eur J Pediatr. 1982. PMID: 7128646 No abstract available.
-
Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.Drug Saf. 2010 Nov 1;33(11):995-1002. doi: 10.2165/11538280-000000000-00000. Drug Saf. 2010. PMID: 20925437
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
